Comparison of oral fluconazole versus itraconazole for treatment of recurrent oral candidiasis

Authors

  • Zaib DHQ Teaching Hospital/ Sargodha Medical College, University of Sargodha, Sargodha
  • Farwa Naqvi Sargodha Medical College , University of Sargodha, Sargodha
  • Saira Mohsin Zahida Walfare Hospital Lahore
  • Nadeem Yaqoob Niazi Medical and Dental College Sargodha
  • Abdul Mudabbir Rehan D.G. Khan Medical and Dental College, Dera Ghazi Khan
  • Ahmad Amin Khan Fraz Amin Medical Center, Chiniot

DOI:

https://doi.org/10.66344/jpad.v31i2.1744

Abstract

Objective To compare the efficacy of oral fluconazole versus itraconazole in oral candidiasis.

Methods This study was conducted at the Outpatient Department of Dermatology, DHQ Teaching Hospital, Sargodha Medical College Sargodha. A total of 240 patients were included in this study were divided into two groups containing 120 patients in each group. Both groups applied 2% miconazole gel orally thrice daily for 7-14 days. In addition, group A was prescribed fluconazole 50mg once daily and group B was prescribed itraconazole 100mg twice daily for 7-14 days. Each patient was followed up monthly either physically or on phone for 6 months.

Results In group A, the total number of 45 patients (37.5%) reported back with oral candidiasis whereas 19 patients (15.83%) of group B reported back with oral candidiasis.

Conclusion It is concluded that itraconazole is better than fluconazole for the treatment of recurrent oral candidiasis with a similar duration of treatment.

Author Biographies

  • Zaib, DHQ Teaching Hospital/ Sargodha Medical College, University of Sargodha, Sargodha

    Department of Dermatology

  • Saira Mohsin, Zahida Walfare Hospital Lahore

    Department of Dermatology

  • Nadeem Yaqoob, Niazi Medical and Dental College Sargodha

    Department of Pharmacology

  • Abdul Mudabbir Rehan, D.G. Khan Medical and Dental College, Dera Ghazi Khan

    Department of Pharmacology

References

1. van Boven JFM, Vegter S. Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis. Drug Saf. 2013; 36(4):231–6.

2. Hoshi N, Mori H, Taguchi H, Taniguchi M, Aoki H, Sawada T, et al. Management of oral candidiasis in denture wearers. J Prosthodont Res. 2011;55(1):48-52.

3. Rashid S, Naqvi F, Inayat S, Ilyas A, Faraz AAK. Frequency of undiagnosed diabetes mellitus in patients with vaginal candidiasis. J Pakistan Assoc Dermatol. 2020; 30(2):323–6.

4. Imran I, Butt IM, Naqvi F, Mansoor M, Chiragh S. Antidiabetic and Antinephropathic Potential of Ajwa Pit & Pulp (Phoenix dactylifera) in Alloxanized Diabetic Rats. In: Proceedings. 2020. p. 39–43.

5. Akpan A, Morgan R. Oral candidiasis. Postgrad Med J. 2002;78(922):455–9.

6. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38(2):161-89.

7. Goins RA, Ascher D, Waecker N, Arnold J, Moorefield E. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants. Pediatr Infect Dis J. 2002;21(12):1165-7.

8. Reddy RCJ, Jeelani S, Duraiselvi P, Kandasamy M, Kumar GS, Pandian RAV. Assessment of effectiveness of fluconazole and clotrimazole in treating oral candidiasis patients: A comparative study. J Int Soc Prev Community Dent. 2017;7(2):90.

Downloads

Published

06.08.2021

Issue

Section

Original Articles

How to Cite

1.
Comparison of oral fluconazole versus itraconazole for treatment of recurrent oral candidiasis. J Pak Assoc Dermatol [Internet]. 2021 Aug. 6 [cited 2026 Sep. 16];31(2):245-9. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1744